Role for transcription factor TFII-I in the suppression of SSeCKS/Gravin/Akap12 transcription by Src

International Journal of Cancer

Volumn 128, Issue 8, 2011, Pages 1836-1842

  Bu, Yahao ^a   Gao, Lingqiu ^b   Gelman, Irwin H ^b  

^a Kinex Pharmaceuticals LLC   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Gtf2i; HDAC1; mass spectrometry; Sp1; Sp3; Src; SSeCKS Gravin AKAP12; TFII I; USF1

Indexed keywords

CELL PROTEIN; HISTONE DEACETYLASE 1; PROTEIN AKAP12; PROTEIN GRAVIN; PROTEIN SSECKS; PROTEIN TYROSINE KINASE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR II; TRANSCRIPTION FACTOR II I; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3; TYROSINE; UNCLASSIFIED DRUG; UPSTREAM STIMULATORY FACTOR 1;

ANIMAL CELL; ARTICLE; CELL NUCLEUS; CELL STRAIN 3T3; CELL TRANSFORMATION; CONTROLLED STUDY; GENE SILENCING; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; RNA INTERFERENCE; TRANSCRIPTION REGULATION;

A KINASE ANCHOR PROTEINS; ANIMALS; BLOTTING, WESTERN; CELL CYCLE PROTEINS; CHROMATIN IMMUNOPRECIPITATION; CHROMATOGRAPHY, LIQUID; DOWN-REGULATION; GENE EXPRESSION REGULATION; IMMUNOPRECIPITATION; MICE; NIH 3T3 CELLS; PHOSPHORYLATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SRC-FAMILY KINASES; TRANSCRIPTION FACTORS, TFII; TRANSCRIPTION, GENETIC;

EID: 79951994751     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25524     Document Type: Article

References (38)

1. Frame MC,. Newest findings on the oldest oncogene; how activated src does it. J Cell Sci 2004; 117: 989-98. (Pubitemid 38456081)
2. Jove R, Hanafusa H,. Cell transformation by the viral src oncogene. Ann Rev Cell Biol 1987; 3: 31-56.
3. Dehbi M, Bedard P-A,. Regulation of gene expression in oncogenically transformed cells. Biochem Cell Biol 1993; 70: 980-97.
4. Bild AH, Yao G, Chang JT, Wang Q, Potti A, Chasse D, Joshi MB, Harpole D, Lancaster JM, Berchuck A, Olson JA, Jr, Marks JR, et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 2006; 439: 353-7. (Pubitemid 43128862)
5. Liu Y, Gao L, Gelman IH,. SSeCKS/Gravin/AKAP12 attenuates expression of proliferative and angiogenic genes during suppression of v-Src-induced oncogenesis. BMC Cancer 2006; 6: 105-17.
6. Acharya CR, Hsu DS, Anders CK, Anguiano A, Salter KH, Walters KS, Redman RC, Tuchman SA, Moylan CA, Mukherjee S, Barry WT, Dressman HK, et al. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer. JAMA 2008; 299: 1574-87. (Pubitemid 351482796)
7. Creighton CJ,. Multiple oncogenic pathway signatures show coordinate expression patterns in human prostate tumors. PLoS One 2008; 3: e1816.
8. Sabbah M, Emami S, Redeuilh G, Julien S, Prevost G, Zimber A, Ouelaa R, Bracke M, De Wever O, Gespach C,. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers. Drug Resist Updat 2008; 11: 123-51.
9. Zhang XH, Wang Q, Gerald W, Hudis CA, Norton L, Smid M, Foekens JA, Massague J,. Latent bone metastasis in breast cancer tied to Src-dependent survival signals. Cancer Cell 2009; 16: 67-78.
10. Leupold JH, Asangani I, Maurer GD, Lengyel E, Post S, Allgayer H,. Src induces urokinase receptor gene expression and invasion/intravasation via activator protein-1/p-c-Jun in colorectal cancer. Mol Cancer Res 2007; 5: 485-96. (Pubitemid 46908466)
11. Noti JD, Reinemann BC, Petrus MN,. Sp1 binds two sites in the CD11c promoter in vivo specifically in myeloid cells and cooperates with AP1 to activate transcription. Mol Cell Biol 1996; 16: 2940-50. (Pubitemid 26161300)
12. Rivat C, Le Floch N, Sabbah M, Teyrol I, Redeuilh G, Bruyneel E, Mareel M, Matrisian LM, Crawford HC, Gespach C, Attoub S,. Synergistic cooperation between the AP-1 and LEF-1 transcription factors in the activation of the matrilysin promoter by the src oncogene: implications in cellular invasion. FASEB J 2003; 17: 1721-3.
13. Xie W, Herschman HR,. v-src induces prostaglandin synthase 2 gene expression by activation of the c-Jun N-terminal kinase and the c-Jun transcription factor. J Biol Chem 1995; 270: 27622-8.
14. Bu Y, Gelman IH,. v-Src-mediated down-regulation of SSeCKS metastasis suppressor gene promoter by the recruitment of HDAC1 into a USF1-Sp1-Sp3 Complex. J Biol Chem 2007; 282: 26725-39. (Pubitemid 47501893)
15. Pierani A, Pouponnot C, Calothy G,. Transciptional downregulation of the retina-specific QR1 gene by pp60v-src and identification of a novel v-src responsive unit. Mol Cell Biol 1993; 13: 3401-14. (Pubitemid 23157277)
16. Provot S, Pouponnot C, Lecoq O, Calothy G, Felder-Schmittbuhl MP,. Characterization of a novel quiescence responsive element downregulated by v-Src in the promoter of the neuroretina specific QR1 gene. Oncogene 2000; 19: 4736-45.
17. Verde P, Casalino L, Talotta F, Yaniv M, Weitzman JB,. Deciphering AP-1 function in tumorigenesis: fra-ternizing on target promoters. Cell Cycle 2007; 6: 2633-9. (Pubitemid 350224046)
18. Wierstra I,. Sp1: emerging rolesâbeyond constitutive activation of TATA-less housekeeping genes. Biochem Biophys Res Commun 2008; 372: 1-13.
19. Roy AL,. Transcription factor TFII-I conducts a cytoplasmic orchestra. ACS Chem Biol 2006; 1: 619-22.
20. Kim DW, Cheriyath V, Roy AL, Cochran BH,. TFII-I enhances activation of the c-fos promoter through interactions with upstream elements. Mol Cell Biol 1998; 18: 3310-20. (Pubitemid 28240503)
21. Novina CD, Cheriyath V, Roy AL,. Regulation of TFII-I activity by phosphorylation. J Biol Chem 1998; 273: 33443-8. (Pubitemid 29005725)
22. Sacristan C, Schattgen SA, Berg LJ, Bunnell SC, Roy AL, Rosenstein Y,. Characterization of a novel interaction between transcription factor TFII-I and the inducible tyrosine kinase in T cells. Eur J Immunol 2009; 39: 2584-95.
23. Sacristan C, Tussie-Luna MI, Logan SM, Roy AL,. Mechanism of Bruton's tyrosine kinase-mediated recruitment and regulation of TFII-I. J Biol Chem 2004; 279: 7147-58. (Pubitemid 38248862)
24. Cheriyath V, Desgranges ZP, Roy AL,. c-Src-dependent transcriptional activation of TFII-I. J Biol Chem 2002; 277: 22798-805. (Pubitemid 34967260)
25. Cheriyath V, Roy AL,. Alternatively spliced isoforms of TFII-I. Complex formation, nuclear translocation, and differential gene regulation. J Biol Chem 2000; 275: 26300-8.
26. Hakre S, Tussie-Luna MI, Ashworth T, Novina CD, Settleman J, Sharp PA, Roy AL,. Opposing functions of TFII-I spliced isoforms in growth factor-induced gene expression. Mol Cell 2006; 24: 301-8. (Pubitemid 44557127)
27. Ku M, Sokol SY, Wu J, Tussie-Luna MI, Roy AL, Hata A,. Positive and negative regulation of the transforming growth factor beta/activin target gene goosecoid by the TFII-I family of transcription factors. Mol Cell Biol 2005; 25: 7144-57. (Pubitemid 41105911)
28. Tussie-Luna MI, Bayarsaihan D, Seto E, Ruddle FH, Roy AL,. Physical and functional interactions of histone deacetylase 3 with TFII-I family proteins and PIASxbeta. Proc Natl Acad Sci USA 2002; 99: 12807-12.
29. Hakimi MA, Dong Y, Lane WS, Speicher DW, Shiekhattar R,. A candidate X-linked mental retardation gene is a component of a new family of histone deacetylase-containing complexes. J Biol Chem 2003; 278: 7234-9. (Pubitemid 36800724)
30. Lin X, Tombler E, Nelson PJ, Ross M, Gelman IH,. A novel src- and ras-suppressed protein kinase C substrate associated with cytoskeletal architecture. J Biol Chem 1996; 271: 28430-8. (Pubitemid 26374662)
31. Safe S, Abdelrahim M,. Sp transcription factor family and its role in cancer. Eur J Cancer 2005; 41: 2438-48. (Pubitemid 41540621)
32. Hagen G, Muller S, Beato M, Suske G,. Sp1-mediated transcriptional activation is repressed by Sp3. EMBO J 1994; 13: 3843-51. (Pubitemid 24275030)
33. Choi HS, Lee JH, Park JG, Lee YI,. Trichostatin A, a histone deacetylase inhibitor, activates the IGFBP-3 promoter by upregulating Sp1 activity in hepatoma cells: alteration of the Sp1/Sp3/HDAC1 multiprotein complex. Biochem Biophys Res Commun 2002; 296: 1005-12.
34. Doetzlhofer A, Rotheneder H, Lagger G, Koranda M, Kurtev V, Brosch G, Wintersberger E, Seiser C,. Histone deacetylase 1 can repress transcription by binding to Sp1. Mol Cell Biol 1999; 19: 5504-11. (Pubitemid 29339908)
35. Zhao S, Venkatasubbarao K, Li S, Freeman JW,. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells. Cancer Res 2003; 63: 2624-30. (Pubitemid 36605205)
36. Roy AL, Du H, Gregor PD, Novina CD, Martinez E, Roeder RG,. Cloning of an inr- and E-box-binding protein, TFII-I, that interacts physically and functionally with USF1. EMBO J 1997; 16: 7091-104. (Pubitemid 27520808)
37. Owen HR, Elser M, Cheung E, Gersbach M, Kraus WL, Hottiger MO,. MYBBP1a is a novel repressor of NF-kappaB. J Mol Biol 2007; 366: 725-36.
38. Achour M, Fuhrmann G, Alhosin M, Ronde P, Chataigneau T, Mousli M, Schini-Kerth VB, Bronner C,. UHRF1 recruits the histone acetyltransferase Tip60 and controls its expression and activity. Biochem Biophys Res Commun 2009; 390: 523-8.